HIV Citation List: November 12 - November 23, 2010

Pubmed citations:

1. Structure-based design, synthesis, and structure-activity relationship studies of HIV-1 protease inhibitors incorporating phenyloxazolidinones. Ali, A., G.S. Reddy, M.N. Nalam, S.G. Anjum, H. Cao, C.A. Schiffer, and T.M. Rana. Journal of Medicinal Chemistry, 2010. 53(21): p. 7699-7708; PMID[20958050].

[Pubmed]. HIV_1112-112410.

2. Discovery of Entry Inhibitors for HIV-1 via a New De Novo Protein Design Framework. Bellows, M.L., M.S. Taylor, P.A. Cole, L. Shen, R.F. Siliciano, H.K. Fung, and C.A. Floudas. Biophysical Journal, 2010. 99(10): p. 3445-3453; PMID[21081094].

[Pubmed]. HIV_1112-112410.

3. In-vitro phenotypic susceptibility of HIV-2 clinical isolates to the integrase inhibitor S/GSK1349572. Charpentier, C., L. Larrouy, G. Collin, F. Damond, S. Matheron, G. Chene, T. Nie, R. Schinazi, F. Brun-Vezinet, and D. Descamps. Aids, 2010. 24(17): p. 2753-2755; PMID[20827161].

[Pubmed]. HIV_1112-112410.

4. Xiamycin, a pentacyclic indolosesquiterpene with selective anti-HIV activity from a bacterial mangrove endophyte. Ding, L., J. Munch, H. Goerls, A. Maier, H.H. Fiebig, W.H. Lin, and C. Hertweck. Bioorganic & Medicinal Chemistry Letters, 2010. 20(22): p. 6685-6687; PMID[20880706].

[Pubmed]. HIV_1112-112410.

5. Triterpene derivatives that inhibit human immunodeficiency virus type 1 replication. Dorr, C.R., S. Yemets, O. Kolomitsyna, P. Krasutsky, and L.M. Mansky. Bioorganic & Medicinal Chemistry Letters, 2010. [Epub ahead of print]; PMID[21084190].

[Pubmed]. HIV_1112-112410.

6. Development of the next generation of HIV-1 integrase inhibitors: pyrazolone as a novel inhibitor scaffold. Hadi, V., Y.H. Koh, T.W. Sanchez, D. Barrios, N. Neamati, and K.W. Jung. Bioorganic & Medicinal Chemistry Letters, 2010. 20(22): p. 6854-6857; PMID[20864343].

[Pubmed]. HIV_1112-112410.

7. Antiviral Activity, Pharmacokinetics, and Safety of BMS-488043, a Novel Oral Small-Molecule HIV-1 Attachment Inhibitor, in HIV-1-Infected Subjects. Hanna, G.J., J. Lalezari, J.A. Hellinger, D.A. Wohl, R. Nettles, A. Persson, M. Krystal, P. Lin, R. Colonno, and D.M. Grasela. Antimicrobial Agents & Chemotherapy, 2010. [Epub ahead of print]; PMID[21078951].

[Pubmed]. HIV_1112-112410.

8. Solid-phase synthesis and screening of N-acylated polyamine (NAPA) combinatorial libraries for protein binding. Iera, J.A., L.M. Jenkins, H. Kajiyama, J.B. Kopp, and D.H. Appella. Bioorganic & Medicinal Chemistry Letters, 2010. 20(22): p. 6500-6503; PMID[20932761].

[Pubmed]. HIV_1112-112410.

9. Attachment and fusion inhibitors potently prevent dendritic cell-driven HIV infection. Ines, F. and R. Melissa. Journal of Acquired Immune Deficiency Syndromes, 2010. [Epub ahead of print]; PMID[21084994].

[Pubmed]. HIV_1112-112410.

10. Discovery and SAR of a series of 4,6-diamino-1,3,5-triazin-2-ol as novel non-nucleoside reverse transcriptase inhibitors of HIV-1. Liu, B., Y. Lee, J. Zou, H.M. Petrassi, R.W. Joseph, W. Chao, E.L. Michelotti, M. Bukhtiyarova, E.B. Springman, and B.D. Dorsey. Bioorganic & Medicinal Chemistry Letters, 2010. 20(22): p. 6592-6596; PMID[20888224].

[Pubmed]. HIV_1112-112410.

11. Amyloid-binding Small Molecules Efficiently Block SEVI (Semen-derived Enhancer of Virus Infection)- and Semen-mediated Enhancement of HIV-1 Infection. Olsen, J.S., C. Brown, C.C. Capule, M. Rubinshtein, T.M. Doran, R.K. Srivastava, C. Feng, B.L. Nilsson, J. Yang, and S. Dewhurst. Journal of Biological Chemistry, 2010. 285(46): p. 35488-35496; PMID[20833717].

[Pubmed]. HIV_1112-112410.

12. Chemoenzymatic Syntheses and Anti-HIV-1 Activity of Glucose-Nucleoside Conjugates as Prodrugs. Rodriguez-Perez, T., S. Fernandez, Y.S. Sanghvi, M. Detorio, R.F. Schinazi, V. Gotor, and M. Ferrero. Bioconjugate Chemistry, 2010. [Epub ahead of print]; PMID[21077659].

[Pubmed]. HIV_1112-112410.

13. Potent and selective HIV-1 ribonuclease H inhibitors based on a 1-hydroxy-1,8-naphthyridin-2(1H)-one scaffold. Williams, P.D., D.D. Staas, S. Venkatraman, H.M. Loughran, R.D. Ruzek, T.M. Booth, T.A. Lyle, J.S. Wai, J.P. Vacca, B.P. Feuston, L.T. Ecto, J.A. Flynn, D.J. DiStefano, D.J. Hazuda, C.M. Bahnck, A.L. Himmelberger, G. Dornadula, R.C. Hrin, K.A. Stillmock, M.V. Witmer, M.D. Miller, and J.A. Grobler. Bioorganic & Medicinal Chemistry Letters, 2010. 20(22): p. 6754-6757; PMID[20869872].

[Pubmed]. HIV_1112-112410.

14. Synthesis of N-Terminally Linked Protein and Peptide Dimers by Native Chemical Ligation. Xiao, J., B.S. Hamilton, and T.J. Tolbert. Bioconjugate Chemistry, 2010. 21(11): p. 1943-1947; PMID[20973495].

[Pubmed]. HIV_1112-112410.

15. In Vivo Resistance Patterns to the HIV Attachment Inhibitor BMS-488043. Zhou, N., B. Nowicka-Sans, S. Zhang, L. Fan, J. Fang, H. Fang, Y.F. Gong, B. Eggers, D.R. Langley, T. Wang, J. Kadow, D. Grasela, G.J. Hanna, L. Alexander, R. Colonno, M. Krystal, and P.F. Lin. Antimicrobial Agents & Chemotherapy, 2010. [Epub ahead of print]; PMID[21078948].

[Pubmed]. HIV_1112-112410.

ISI Web of Knowledge citations:

16. QSAR Studies on the Calanolide Analogues as Anti-HIV-1 Agents. Qiu, K.X., H.D. Xie, Y.P. Guo, Y. Huang, B. Liu, and W. Li. Chinese Journal of Structural Chemistry, 2010. 29(10): p. 1477-1482; ISI[000283481700004].

[WOS]. HIV_1112-112410.

17. Advances in Aptamers. Syed, M.A. and S. Pervaiz. Oligonucleotides, 2010. 20(5): p. 215-224; ISI[000283489700001].

[WOS]. HIV_1112-112410.

18. Synthesis and Antiviral Activity of New Indole-Based Heterocycles. Abdel-Gawad, H., H.A. Mohamed, K.M. Dawood, and F.A.R. Badria. Chemical & Pharmaceutical Bulletin, 2010. 58(11): p. 1529-1531; ISI[000283522300019].

[WOS]. HIV_1112-112410.

19. Human Immunodeficiency Virus Type 1 Protease Inhibitor Drug-Resistant Mutants Give Discordant Results When Compared in Single-Cycle and Multiple-Cycle Fitness Assays. Dykes, C., H.L. Wu, M. Sims, J. Holden-Wiltse, and L.M. Demeter. Journal of Clinical Microbiology, 2010. 48(11): p. 4035-4043; ISI[000283588500030].

[WOS]. HIV_1112-112410.

20. Naturally occurring circular proteins: distribution, biosynthesis and evolution. Cascales, L. and D.J. Craik. Organic & Biomolecular Chemistry, 2010. 8(22): p. 5035-5047; ISI[000283602000001].

[WOS]. HIV_1112-112410.

21. Deriving four functional anti-HIV siRNAs from a single Pol III-generated transcript comprising two adjacent long hairpin RNA precursors. Saayman, S., P. Arbuthnot, and M.S. Weinberg. Nucleic Acids Research, 2010. 38(19): p. 6652-6663; ISI[000283682100036].

[WOS]. HIV_1112-112410.

22. Synthesis, antiviral and contraceptive activities of nucleoside-sodium cellulose sulfate acetate and succinate conjugates. Agarwal, H.K., A. Kumar, G.F. Doncel, and K. Parang. Bioorganic & Medicinal Chemistry Letters, 2010. 20(23): p. 6993-6997; ISI[000283801400025].

[WOS]. HIV_1112-112410.

23. QSAR Studies of 3,3 '-(Substituted-benzylidene)-bis-4-hydroxycoumarin, Potential HIV-1 Integrase Inhibitor. Li, B.J., C.C. Chiang, and L.Y. Hsu. Journal of the Chinese Chemical Society, 2010. 57(4A): p. 742-749; ISI[000283803400021].

[WOS]. HIV_1112-112410.